Exploring the Inhibitory Mechanism of Approved Selective Norepinephrine Reuptake Inhibitors and Reboxetine Enantiomers by Molecular Dynamics Study

Abstract

Selective norepinephrine reuptake inhibitors (sNRIs) provide an effective class of approved antipsychotics, whose inhibitory mechanism could facilitate the discovery of privileged scaffolds with enhanced drug efficacy. However, the crystal structure of human norepinephrine transporter (hNET) has not been determined yet and the inhibitory mechanism of sNRIs remains elusive. In this work, multiple computational methods were integrated to explore the inhibitory mechanism of approved sNRIs (atomoxetine, maprotiline, reboxetine and viloxazine), and 3 lines of evidences were provided to verify the calculation results. Consequently, a binding mode defined by interactions between three chemical moieties in sNRIs and eleven residues in hNET was identified as shared by approved sNRIs. In the meantime, binding modes of reboxetine’s enantiomers with hNET were compared. 6 key residues favoring the binding of (S, S)-reboxetine over that of (R, R)-reboxetine were discovered. This is the first study reporting that those 11 residues are the common determinants for the binding of approved sNRIs. The identified binding mode shed light on the inhibitory mechanism of approved sNRIs, which could help identify novel scaffolds with improved drug efficacy.

Performance Evaluation and Online Realization of Data-driven Normalization Methods Used in LC/MS based Untargeted Metabolomics Analysis

“…The hierarchical clustering568990 was adopted to identify the relationship of sample size dependent performance among 16 methods. Firstly, the area under the curve values (AUCs) of a specific method among 10 sub-datasets of various sample size were used to generate a 10 dimensional vector.…”

Identification of novel immune‐relevant drug target genes for Alzheimer's Disease by combining ontology inference with network analysis

“…In particular, glymphatic (glial+lymphatic) system was a critical contributor to the clearance of interstitial solutes (including Aβ deposits) from the brain, and the function of glymphatic transport was suppressed in a mouse AD model . The malfunction of meningeal lymphatic vessel (the other cleaner of Aβ deposits closely related to lymphatic system) was found to be greatly associated with AD pathogenesis . In the meantime, some immunotherapies and drugs for Aβ clearance have attempted to control progress of AD .…”

Combination of Alarm-intervention and Reboxetine in Therapy- Resistant Enuresis

“…It is known that Reboxetine highly selectively inhibits the reuptake of norepinephrine by presynaptic nerve endings, promotes accumulation of the neurotransmitter in the synaptic cleft, and enhances of noradrenergic transmission 28,29 . A high level of norepinephrine in the presynaptic nerve endings aff ecting on the work of the limbic-reticular formation, changes the structure of sleep.…”